Vaccination with lethally irradiated glioma cells mixed with GM-K562 cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vaccination with lethally irradiated glioma cells mixed with GM-K562 cells, covering 2017-06-22 to 2017-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor [Phase 1]